[SCHF] Schwab International Equity ETF

Overview

Type of security: Fund

Tags: Blend, Broad ex-US, Developed markets, Equity, ETF, ex-US, Index Based, International, Large-cap, Not Inversed, Regional, Stocks, Unleveraged

The data is delayed by 15 minutes.

 

Price: 27.66 Change: 0.03 (0.11%)
Ext. hours: Change: 0 (0%)

chart SCHF

Refresh chart

Strongest Trends Summary For SCHF

SCHF is in the medium-term down -5% below S&P in 1 year. In the long-term down -18% below S&P in 3 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: The investment seeks to track as closely as possible, before fees and expenses, the total return of the FTSE Developed ex US Index. The fund invests at least 90% of net assets in stocks that are included in the index. The index is comprised of large and mid capitalization companies in developed countries outside the United States, as defined by the index provider. It will concentrate its investments (i.e., hold 25% or more of its total assets) in a particular industry, group of industries or sector to approximately the same extent that its index is so concentrated. The fund may invest up to 10% of its net assets in securities not included in its index.

Technical Data
High 52 week32.52 Low 52 week27.44 Last close32.26 Last change1.1%
RSI56.85 Average true range0.32 Beta1.04 Volume1.62 M
Simple moving average 20 days1.81% Simple moving average 50 days3.28% Simple moving average 200 days3.77%
Performance Data
Performance Week3.9% Performance Month1% Performance Quart0.94% Performance Half1.03%
Performance Year5.58% Performance Year-to-date13.79% Volatility daily0.77% Volatility weekly1.73%
Volatility monthly3.54% Volatility yearly12.28% Relative Volume326.99% Average Volume3.04 M
New High New Low
Funds Characteristics
30-day SEC yield Average market capitalization Average weighted market capitalization Forward P/E
Gross expense ratio Index dividend yield Median market cap Number of holdings
Price to Book Value Price to Earnings Total expense ratio Total net assets
Weighted market capitalization

News

2019-11-18 10:54:33 | How to Get International Equity Exposure on The Cheap

2019-11-18 08:11:25 | A Schwab ETF For Accessing International Equities At A Nominal Fee

2019-11-15 01:00:00 | Low-Cost, Diversified Exposure to Foreign Developed Markets

2019-07-03 07:00:00 | Easy Ways to Manage Risk

2019-06-25 09:33:41 | A Deal on Developed Markets Exposure IEFA, EFA

2019-05-03 15:09:00 | How to Use ETFs to Tap into Global Opportunities

2019-01-01 20:43:01 | New International ETF Enters Market

2018-12-17 08:00:18 | Schwab Puts Clients First As Asset Growth Outpaces ETF Industry

2018-12-12 10:40:11 | Joy to the World and These 5 Developed Market ETFs

2018-10-29 11:53:45 | A Cost-Effective Developed Markets ETF

2018-10-29 10:52:23 | A Cheap International ETF Trip

2018-10-26 07:00:00 | Cheap, Diversified Exposure to Foreign Developed Markets

2018-10-24 07:00:00 | The Currency Hedging Dilemma

2018-05-11 09:45:02 | Analyzing the Possible Impacts of the Iran Deal Exit

2017-11-08 19:31:00 | 3 ETFs to Help You Build Retirement Wealth

2017-08-29 15:56:45 | A Deeper Dive Into ESG ETF Portfolios

2017-07-25 09:09:27 | Novartis in 2Q17: Performance of Alcon

2017-07-18 13:25:46 | Rapid Growth For This International ETF

2017-07-18 07:39:23 | Novartis’s 2Q17 Estimates: How Sandoz Might Perform

2017-07-07 15:51:31 | Novartis Stock in 2Q17: How Has It Performed?

2017-07-06 11:02:00 | 3 Top International ETFs for 2017 and Beyond

2017-06-19 09:07:00 | The Single-Best Retirement Fund Booster

2017-06-01 10:37:41 | Inside Novartis’s Innovative Medicines Segment in 1Q17

2017-06-01 07:38:39 | GlaxoSmithKline’s Pharmaceuticals Segment in 1Q17

2017-05-30 07:38:07 | How AstraZeneca’s Growth Platforms Performed in 1Q17

2017-05-26 10:37:50 | Performance of Sanofi Genzyme in 1Q17

2017-04-28 10:37:38 | Novartis’s 1Q17 Earnings: Recent Developments

2017-04-11 12:00:00 | A Deal on Developed Markets Exposure

2017-03-27 07:38:22 | Novartis’s Recent Developments

2017-01-31 22:50:00 | Charles Schwab Lowers Fees On ETFs

2017-01-16 07:37:38 | How Does Novartis’s Valuation Compare to Peers?

2016-12-09 12:43:02 | Van Eck Leads ETF Issuer Growth This Year

2016-11-18 08:00:47 | Tune Up Your ETF Portfolio For A Better And Smoother Investment Journey

2016-11-07 14:28:15 | Will Improving Earnings Help Push Stocks Higher?

2016-10-07 14:54:56 | Schwab Responds to BlackRock’s Latest ETF Price War Salvo

2016-10-07 11:32:58 | Schwab slices fees on 5 ETFs, escalates battle with BlackRock

2016-09-24 08:22:20 | Seismic Shift: What Could It Mean For Stocks?

2016-09-15 14:53:01 | Stop Wasting Energy On The VIX

2016-09-13 08:04:45 | Performance of GSK’s Global Pharmaceuticals Franchises Mixed

2016-08-18 17:44:00 | Top 5 Schwab ETFs of 2016

2016-06-27 08:48:00 | Calculate The Odds Of A Portfolio Disaster

2016-05-13 13:54:59 | Why an Unmoved Bank of Japan in April Shook Up Japanese Equities

2016-04-22 11:14:41 | The Heroic Assumptions Behind The Current Stock Market Rally

2016-01-07 08:15:00 | The Top 10 Core Equity ETFs for 2016 SCHD, EFV

2015-11-17 08:30:01 | International Equity ETFs Without the High Costs

2015-11-12 16:00:09 | Smart-Beta ETF Buying Guide

2015-11-10 08:56:05 | iShares Enters World's Cheapest ETF Portfolio

2015-10-08 17:30:05 | Play Your ETF Portfolio Like The Rich Do

2015-09-25 07:00:00 | Currency-Hedged ETFs Still Popular

2015-08-18 05:00:00 | Best ETFs: Diversified International Funds